Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation.

Cao, Chunhao; Zhao, Wenting; Chen, Xianglin; Shen, Bin; Wang, Teng; Wu, Chaoxu; Rong, Xiaofeng

Cao, Chunhao; Zhao, Wenting; Chen, Xianglin; Shen, Bin; Wang, Teng; Wu, Chaoxu; Rong, Xiaofeng.

Afiliação

Cao C; Department of Integrated Traditional Chinese and Western Medicine, The First Affiliate Hospital of Chongqing Medical University, Chongqing, China.
Zhao W; Hubei University of Chinese Medicine, Wuhan, China.
Chen X; Hubei University of Chinese Medicine, Wuhan, China.
Shen B; Chongqing Medical University, Chongqing, China.
Wang T; Chongqing Medical University, Chongqing, China.
Wu C; Department of Integrated Traditional Chinese and Western Medicine, The First Affiliate Hospital of Chongqing Medical University, Chongqing, China.
Rong X; Department of Integrated Traditional Chinese and Western Medicine, The First Affiliate Hospital of Chongqing Medical University, Chongqing, China.

Front Pharmacol ; 13: 1032282, 2022.

Article em En | MEDLINE | ID: mdl-36339551

Palavras-chave

WGCNA; network pharmacology; p38 MAPK signal pathway; paeoniflorin; pancreatic cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google